Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
The article describes a protocol for reconstituting pasteurized donor milk microbiota using the mother's own milk microbiota in practical, real-world settings. It demonstrates effective bacterial growth and microbiome modulation, supporting the feasible application of this procedure within the routine care of a maternity hospital and its associated human milk bank.
Mother's own milk (MOM) is the most complete nutritional resource for newborns. In cases where mothers are unable to produce sufficient milk or cannot breastfeed, the preferred alternative is pasteurized donor human milk (PDM), which is routinely provided by human milk banks. PDM offers a superior range of nutritional and immunological elements compared to any commercially available formula. However, to ensure biosafety, PDM undergoes pasteurization, a process that inactivates commensal microbiota and reduces certain bioactive compounds. This study presents a protocol designed to restore the microbiota of PDM using MOM as a microbial source, adapting the approach to a real-world clinical setting.
The protocol was implemented in a clinical trial conducted at a maternity hospital and its associated human milk bank, with the aim of providing personalized donor milk to preterm infants whose mothers cannot produce sufficient milk. The methodology involves inoculating PDM with 10% of MOM, followed by incubation at 37 °C for 4 h. Microbiological analysis demonstrated successful bacterial growth in the inoculated milk (IM) post incubation, with the microbiota profile of the reconstituted milk (RM) closely resembling that of MOM, indicating effective microbiota restoration. These results suggest that the reconstitution protocol is feasible for implementation in neonatal care, with the potential to enhance the nutritional and immunological quality of PDM, thereby supporting the health and development of non-breastfed newborns.
Breast milk is widely recognized as the best source of nutrition for newborns, providing not only essential macro and micronutrients but also a complex array of elements, including various metabolites and components of the immune system, such as antibodies, cytokines, and cells1. Additionally, the beneficial properties in breast milk also arise from a community of commensal microorganisms. All these elements of breast milk play a crucial role in the development of the newborn1. The community of microorganisms, known as the microbiota, is influenced by a combination of factors such as diet, maternal lifestyle, type of del....
This protocol was performed as part of the procedures of a clinical trial conducted by our research group (Brazilian Registry of Clinical Trials, ReBEC RBR-729kr8x), and received Ethics Committee approval (process CAAE nº 41063520.4.0 000.0121) and informed consent were obtained from all participants prior to randomization and sample colletction.
The procedure for reconstituting the milk microbiota is done in three steps:
1. Obtaining mother's raw milk
NOTE: The procedure for obtaining milk can be found elsewhere10,
Bacterial growth analysis by plate culturing
The microbiological tests conducted to validate the method of inoculating PDM with the MOM, as proposed by Cacho et al.9, demonstrated that, based on the CFU/mL count, there were no significant differences between the inoculated milk samples before and after the 4 h incubation. However, differences in the number of colonies were observed at these two time points, indicating bacterial growth during incubation on MSA for Staphyl.......
Here we present a protocol to be applied in maternity hospitals associated with a human milk bank, aiming to provide PDM with the reconstitution of the milk microbiota from a specific mother who, for various reasons, cannot provide sufficient milk to her newborn. The protocol is simple and essentially based on two steps. The first involves the application of procedures routinely performed in human milk banks for the proper collection and subsequent pasteurization of donor milk, as well as the collection of the mother's o.......
The authors declare that they have no competing interests.
The authors gratefully acknowledge funding support from the Programa de Pesquisas para o SUS, PPSUS/2020, Ministério da Saúde do Brasil; Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina, Grant Number: 2021TR000506; Programa de Pesquisa Universal, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) do Ministério de Ciência e Tecnologia do Brasil, Grant Number: 420996/2023-0; Programa Institucional de Bolsas de Iniciação Científica 2022 - 2024, Grant Number: 120815/2023-0. We also thank the volunteers for providing samples.
....Name | Company | Catalog Number | Comments |
Electric breast milk pump | Horigen | XN-2219M2 | Soft pump dual plus |
Pyrex media bottles | Corning | CLS1395100 | Glass containers with plastic lids |
1000 µL pipette Labmate pro | Corning HTL SA | 5666 | Variable volume pipettor |
Cryogenic vial | Corning | CLS431417 | DNase/RNase-free 2 mL vials |
15 mL centrifuge tubes | Corning | CLS431470 | DNase/RNase-free 15 mL tubes |
Water bath | EcoSonics | Q3.0/40A | |
Man–Rogosa–Sharpe (MRS) | Difco | 288210 | Lactic acid bacteria growth media |
Mannitol Salt Agar (MSA) | Himedia | MH118 | Staphylococcus growth media |
Anaerobic Jar | Permution | Create a low-oxygen environment for lactic acid bacteria growth | |
Extracta Kit – DNA e RNA | Loccus | MPTA-PV16-B Y | DNA extraction Kit |
Nanodrop | Promega | E6150 | Quantus DNA |
GoTaqG2 | Promega | M7841 | PCR amplication System |
Quantus Fluorometer | Promega | E5150 | DNA / RNA quantitation kit |
MiSeq System | Illumina Inc. | M-GL-00006 v4.0 | Sequencing equipment |
MiSeq Reagent Kit v2 (300-cycles) | Illumina Inc. | MS-102-2002 | Sequencing kits and reagents |
Software name | |||
Trimmomatic | http://www.usadellab.org/cms/index.php?page=trimmomatic | Read trimming tool for Illumina NGS data | |
QIIME 2 | https://docs.qiime2.org/2024.10/ | Microbiome analysis package | |
Primer name | Primer sequence | ||
16S_357F | TCGTCGGCAGCGTCAGA TGTGTATAAGAGACAGC CTACGGGNGGCWGCAG | ||
16S_805R | GTCTCGTGGGCTCGGAG ATGTGTATAAGAGACAGG ACTACHVGGGTATCTAATC |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone